LEXX Message Board Post 12677620 | Lexaria Bioscience Corp.
home / stock / lexx / lexx message board
jamesth
(investorshub)
Posted on: May/11/2023 16:01:43
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171888489
As we look towards 2022 and 2023, Lexaria
News, Short Squeeze, Breakout and More Instantly...
Lexaria Bioscience Corp. Company Name:
LEXX Stock Symbol:
Market:
-
Lexaria, a global innovator in drug delivery platforms, just concluded its first dosing for its glucagon-peptide-1 (“GLP-1”) human pilot study #2, GLP-1-H24-2 GLP-1, a class of drugs, has demonstrated the ability to address diabetes and weight loss, albeit with poor oral bioavaila...
-
Lexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global innovator in drug-delivery platforms, is partnering with a contract research organization (“CRO”) to conduct its human pilot study #3. According to the announcement, this is the first-ever DehydraTECH(TM)-processed tirzepatide from...
-
(TheNewswire) First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral format Kelowna, British Columbia – May 23, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company”...